CD8A and rhabdomyosarcoma: APN deletion in vivo significantly promoted the accumulation of host CD8+ T cells in rhabdomyosarcoma tumor masses as well as in spleen and lymph nodes, and this antitumor effect could be abrogated by a CD8 mAb blockade.